kt 5823 has been researched along with cp 101,606 in 1 studies
Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (cp 101,606) | Trials (cp 101,606) | Recent Studies (post-2010) (cp 101,606) |
---|---|---|---|---|---|
317 | 0 | 59 | 93 | 6 | 31 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ito, S; Katano, T; Mabuchi, T; Matsumura, S; Mishina, M; Okuda-Ashitaka, E; Sakimura, K; Xu, L | 1 |
1 other study(ies) available for kt 5823 and cp 101,606
Article | Year |
---|---|
Nitric oxide (NO) serves as a retrograde messenger to activate neuronal NO synthase in the spinal cord via NMDA receptors.
Topics: Animals; Carbazoles; Cyclic GMP; Dizocilpine Maleate; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type I; Piperidines; Receptors, N-Methyl-D-Aspartate; Spinal Cord | 2007 |